Abstract Global supply chains, once optimized for efficiency and cost reduction, are now confronting a multifaceted array of challenges. This research report delves into the evolving landscape of global supply chains, extending beyond the specific […]
Summary A significant data breach at Union Health System, impacting over 260,000 individuals, highlights the vulnerability of healthcare data. The breach originated from a third-party vendor, Oracle Health/Cerner, emphasizing the need for robust security measures […]
Abstract Modern organizations, particularly those in highly regulated sectors like healthcare, are increasingly reliant on third-party vendors for a myriad of services, ranging from data storage and processing to software development and customer support. While […]
Summary A new wearable device offers real-time breastfeeding data, empowering parents and clinicians to monitor infant nutrition with precision. This technology reduces parental anxiety, improves clinical management of nutrition, and promotes successful breastfeeding, especially for […]
Advancements and Challenges in Neonatal Care: A Comprehensive Review Abstract Neonatal care has witnessed remarkable progress in recent decades, leading to improved survival rates and long-term outcomes for vulnerable newborns. This review provides a comprehensive […]
Abstract Bioimpedance spectroscopy (BIS) is a non-invasive technique that utilizes the electrical properties of biological tissues to assess physiological parameters. This report provides a comprehensive overview of BIS, starting with its fundamental principles based on […]
Summary The FDA has granted Breakthrough Device Designation to Prevencio’s HART CADhs, an AI-driven blood test for obstructive coronary artery disease. This innovative test uses multiple cardiac proteins and machine learning algorithms to provide highly […]
Summary Tirzepatide, a new diabetes drug, has demonstrated superior weight loss results compared to semaglutide in clinical trials involving individuals without diabetes. Participants taking tirzepatide lost up to 20% of their body weight, while those […]
Summary This article discusses the FDA approval of venetoclax and glasdegib, offering new treatment options for older adults with AML who cannot tolerate intensive chemotherapy. These targeted therapies, used in combination with low-dose chemotherapy, provide […]
Abstract Venetoclax, a potent and selective BCL-2 inhibitor, has revolutionized the treatment paradigm for acute myeloid leukemia (AML), particularly in older or unfit patients ineligible for intensive chemotherapy. Its combination with hypomethylating agents (HMAs) such […]
© 2025 Newsguru LTD. All rights reserved.